Cargando…
Pharmacologic Inhibition of Myostatin With a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin‐Deficient Diabetic Mice
Type 1 diabetes (T1D) is associated with low bone and muscle mass, increased fracture risk, and impaired skeletal muscle function. Myostatin, a myokine that is systemically elevated in humans with T1D, negatively regulates muscle mass and bone formation. We investigated whether pharmacologic myostat...
Autores principales: | Bunn, R Clay, Adatorwovor, Reuben, Smith, Rebecca R, Ray, Philip D, Fields, Sarah E, Keeble, Alexander R, Fry, Christopher S, Uppuganti, Sasidhar, Nyman, Jeffry S, Fowlkes, John L, Kalaitzoglou, Evangelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652179/ https://www.ncbi.nlm.nih.gov/pubmed/38025035 http://dx.doi.org/10.1002/jbm4.10833 |
Ejemplares similares
-
Preserving and restoring bone with continuous insulin infusion therapy in a mouse model of type 1 diabetes
por: Nyman, Jeffry S., et al.
Publicado: (2017) -
3152 The role of myostatin in diabetic bone disease
por: Kalaitzoglou, Evangelia, et al.
Publicado: (2019) -
Myostatin in the Pathophysiology of Skeletal Muscle
por: Carnac, Gilles, et al.
Publicado: (2007) -
Muscle and serum myostatin expression in type 1 diabetes
por: Dial, Athan G., et al.
Publicado: (2020) -
Myostatin: A Skeletal Muscle Chalone
por: Lee, Se-Jin
Publicado: (2023)